Moon Surgical raises $55.4M for Maestro commercialization
Moon Surgical raised $55.4 million in additional funding to support continued development and commercialization of its Maestro surgical robot.
Evidence notes
- Sofinnova Partners and NVIDIA were named as leading investors in the financing.
- The capital supported Maestro surgical robotic system development and commercialization.
- Maestro is a collaborative robotic assistant for laparoscopy.